Screener
Palvella Therapeutics PVLA Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Palvella Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Palvella Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210463
FAQ
- What is Palvella Therapeutics's shares (diluted)?
- Palvella Therapeutics (PVLA) reported shares (diluted) of 13.1M in Q1 2026.
- How has Palvella Therapeutics's shares (diluted) changed year-over-year?
- Palvella Therapeutics's shares (diluted) increased by 18.8% year-over-year, from 11M to 13.1M.
- What is the long-term trend for Palvella Therapeutics's shares (diluted)?
- Over 2 years (2021 to 2025), Palvella Therapeutics's shares (diluted) has grown at a -57.9% compound annual growth rate (CAGR), from 250.5M to 44.4M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Palvella Therapeutics's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude